Literature DB >> 28420448

Association of cognitive function and liability to addiction with childhood herpesvirus infections: A prospective cohort study.

Michael M Vanyukov1, Vishwajit L Nimgaonkar1, Levent Kirisci1, Galina P Kirillova1, Maureen D Reynolds1, Konasale Prasad1, Ralph E Tarter1, Robert H Yolken2.   

Abstract

Liability to substance use disorder (SUD) is largely nonspecific to particular drugs and is related to behavior dysregulation, including reduced cognitive control. Recent data suggest that cognitive mechanisms may be influenced by exposure to neurotropic infections, such as human herpesviruses. In this study, serological evidence of exposure to human herpesvirus Herpes simplex virus Type 1 (HSV-1), cytomegalovirus (CMV), and Epstein-Barr virus (EBV) as well as Toxoplasma gondii was determined in childhood (age ~11 years) in 395 sons and 174 daughters of fathers with or without SUD. Its relationships with a cognitive characteristic (IQ) in childhood and with risk for SUD in adulthood were examined using correlation, regression, survival, and path analyses. Exposure to HSV-1, EBV, and T. gondii in males and females, and CMV in males, was associated with lower IQ. Independent of that relationship, EBV in females and possibly in males, and CMV and possibly HSV-1 in females were associated with elevated risk for SUD. Therefore, childhood neurotropic infections may influence cognitive development and risk for behavior disorders such as SUD. The results may point to new avenues for alleviating cognitive impairment and SUD risk.

Entities:  

Mesh:

Year:  2017        PMID: 28420448      PMCID: PMC5648626          DOI: 10.1017/S0954579417000529

Source DB:  PubMed          Journal:  Dev Psychopathol        ISSN: 0954-5794


  60 in total

1.  Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.

Authors:  Konasale M Prasad; Shaun M Eack; Dhruman Goradia; Krishna M Pancholi; Matcheri S Keshavan; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

Review 2.  Sex differences in drug abuse.

Authors:  Jill B Becker; Ming Hu
Journal:  Front Neuroendocrinol       Date:  2007-08-24       Impact factor: 8.606

3.  Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia.

Authors:  K M R Prasad; B H Shirts; R H Yolken; M S Keshavan; V L Nimgaonkar
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

4.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Authors:  K Ahn; T H Meyer; S Uebel; P Sempé; H Djaballah; Y Yang; P A Peterson; K Früh; R Tampé
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

Review 5.  The neurotropic herpes viruses: herpes simplex and varicella-zoster.

Authors:  Israel Steiner; Peter G E Kennedy; Andrew R Pachner
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

Review 6.  The conundrum of causality in tumor virology: the cases of KSHV and MCV.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Semin Cancer Biol       Date:  2013-12-01       Impact factor: 15.707

7.  Association between cytomegalovirus antibody levels and cognitive functioning in non-elderly adults.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Lucy A B Schweinfurth; Christina L G Savage; Robert Yolken
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

Review 8.  Epstein-barr virus vaccines.

Authors:  Jeffrey I Cohen
Journal:  Clin Transl Immunology       Date:  2015-01-23

9.  Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.

Authors:  Jennifer Beam Dowd; Tia Palermo; Jennifer Brite; Thomas W McDade; Allison Aiello
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

Review 10.  Sex differences in pediatric infectious diseases.

Authors:  Maximilian Muenchhoff; Philip J R Goulder
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

View more
  1 in total

1.  Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia.

Authors:  Faith Dickerson; Emily Katsafanas; Andrea Origoni; Amalia Squire; Sunil Khushalani; Theresa Newman; Kelly Rowe; Cassie Stallings; Christina L G Savage; Kevin Sweeney; Tanya T Nguyen; Alan Breier; Donald Goff; Glen Ford; Lorraine Jones-Brando; Robert Yolken
Journal:  Schizophr Res       Date:  2021-01-12       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.